Publikationen IZKS

Originalarbeiten (Zeitschriften) im Jahr 2017

  1. Wiltink J, Ruckes C, Hoyer J, Leichsenring F, Joraschky P, Leweke F, Pöhlmann K, Beutel ME . Transfer of manualized Short Term Psychodynamic Psychotherapy (STPP) for social anxiety disorder into clinical practice: results from a cluster-randomised controlled trial . BMC Psychiatry 2017; 17: Im Druck
  2. Herzog DP, Wagner S, Ruckes C, Tadic A, Roll SC, Härtner M, Lieb K . Guideline adherence of antidepressant treatment in outpatients with major depressive disorder: a naturalistic study. Eur Arch Psychiatry Clin Neurosci 2017; : Im Druck
  3. Franke AG, Gränsmark P, Agricola P, Schühle K, Rommel T, Sebastian A, Balló HE, Gorbulev S, Gerdes C, Frank B, Ruckes C, Tüscher O, Lieb K . Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial. Eur Neuropsychopharmacol 2017; 27: Im Druck
  4. Lorenz K, Wasielica-Poslednik J, Bell K, Renieri G, Keicher A, Ruckes C, Pfeiffer N, Thieme H . Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma. PLoS One 2017; 15: Im Druck
  5. Strehl U, Aggensteiner P, Wachtlin D, Brandeis D, Albrecht B, Arana M, Bach C, Banaschewski T, Flaig-Röhr A, Freitag CM, Fuchsenberger Y, Gest S, Gevensleben H, Herde L, Legenbauer T, Marx AM, Millenet S, Pniewski B, Rothenberger A, Ruckes C, Wörz S, Holtmann M . Neurofeedback of Slow Cortical Potentials in Children with Attention-Deficit/Hyperactivity Disorder: A Multicenter Randomized Trial Controlling for Unspecific Effects. Front Hum Neurosci 2017; : Im Druck
  6. Jaithe LES, Helwig SA, Jaqne A, Ragoschke-Schumm A, Sarr C, Walter S, Lesmeister M, Manitz M, Blaß D, Weis S, Schlund V, Bah N, Kauffmann J, Fousse M, Kangankan S, Ramos Cabrera A, Kronfeld K, Ruckes C, Liu Y, Nyan O, Fassbender K . Standard operating procedures improve acute neurologic care in a sub-Saharan African Setting. Neurology 2017; 89: 144-152
  7. Kahaly GJ, Riedl M, König J, Diana T, Schomburg L . Double-Blind, Placebo-Controlled, Randomized Trial of Selenium in Graves Hyperthyroidism. J Clin Endocrinol Metab 2017; 102: 4333-4341
  8. Ballmann M, Hubert D, Assael BM, Staab D, Hebestreit A, Naehrlich L, Nickolay T, Prinz N, Holl RW, CFRD Study Group . Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial. Lancet Diabetes Endocrinol 2017; : Im Druck

Originalarbeiten (Zeitschriften) im Jahr 2016

  1. Wiltink J, Hoyer J, Beutel ME, Ruckes C, Herpertz S, Joraschky P, Koranyi S, Michal M, Nolting B, Pöhlmann K, Salzer S, Strauss B, Leibing E, Leichsenring F . Do patient characteristics predict outcome of psychodynamic psychotherapy for social anxiety disorder?. PLoS ONE 2016; 11: e0147165
  2. Ferner M, Wachtlin D, Konrad T, Deuster O, Meinertz T, von Bardeleben S, Münzel T, Seibert-Grafe M, Breithardt G, Rostock T . Rationale and design of the RE-LATED AF-AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus-Effects of Dabigatran in patients with Atrial Fibrillation. Clin Res Cardiol 2016; 105: 29-36
  3. Tadić A, Wachtlin D, Berger M, Braus DF, van Calker D, Dahmen N, Dreimüller N, Engel A, Gorbulev S, Helmreich I, Kaiser AK, Kronfeld K, Schlicht KF, Tüscher O, Wagner S, Hiemke C, Lieb K . Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression - the EMC trial. Eur Neuropsychopharmacol 2016; 26: 705-16
  4. Kauff DW, Kronfeld K, Gorbulev S, Wachtlin D, Lang H, Kneist W . Continuous intraoperative monitoring of pelvic autonomic nerves during TME to prevent urogenital and anorectal dysfunction in rectal cancer patients (NEUROS): a randomized controlled trial. BMC Cancer 2016; 16: 323
  5. Riedl M, Kuhn A, Krämer I, Kolbe E, Kahaly GJ . Prospective, systematically recorded mycophenolate safety data in Graves' orbitopathy. J Endocrinol Invest 2016; 39: 687-94
  6. Moehler M, Gepfner-Tuma I, Maderer A, Thuss-Patience PC, Ruessel J, Hegewisch-Becker S, Wilke H, Al-Batran SE, Rafiyan MR, Weißinger F, Schmoll HJ, Kullmann F, von Weikersthal LF, Siveke JT, Weusmann J, Kanzler S, Schimanski CC, Otte M, Schollenberger L, Koenig J, Galle PR . Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program. BMC Cancer 2016; 16: 699
  7. Zahn D, Herpertz S, Albus C, Hermanns N, Hiemke C, Hiller W, Kronfeld K, Kruse J, Kulzer B, Müller MJ, Ruckes C, Petrak F . hs-CRP Predicts Improvement in Depression in Patients With Type 1 Diabetes and Major Depression Undergoing Depression Treatment: Results From the Diabetes and Depression (DAD) Study. Diabetes Care 2016; 39: 171-173

Kommentare sind geschlossen.